IGF-1 level assessment showed that patients with NASH had a lower IGF-1 blood level than the non- or probably-NASH patient groups (101 ng/mL vs. 157 ng/mL, p < 0.006). Here, IGF1 is linked to metabolic dysfunction-associated steatohepatitis.